# Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Study · id `cardio:ct-nct05591118` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05591118](<https://clinicaltrials.gov/study/NCT05591118>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05591118

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 500 participants.

## Technical summary

Registry record NCT05591118. Randomized; no masking; primary purpose treatment. Start 2023-07-17 (actual); primary completion 2027-03-29 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT05591118, source copy `cardio:ctgov-nct05591118-2026-10-28`, retrieved 2026-10-31)
- Started: 2023-07-17 (actual) (ClinicalTrials.gov record NCT05591118, source copy `cardio:ctgov-nct05591118-2026-10-28`, retrieved 2026-10-31)
- Primary completion: 2027-03-29 (anticipated) (ClinicalTrials.gov record NCT05591118, source copy `cardio:ctgov-nct05591118-2026-10-28`, retrieved 2026-10-31)
- Completion: 2027-08-04 (anticipated) (ClinicalTrials.gov record NCT05591118, source copy `cardio:ctgov-nct05591118-2026-10-28`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT05591118, source copy `cardio:ctgov-nct05591118-2026-10-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05591118-2026-10-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
- Acronym: PE-TRACT
- Condition: Pulmonary Embolism
- Intervention (Drug): Anticoagulant Therapy
- Intervention (Device): Catheter-Directed Therapy
- Lead sponsor: NYU Langone Health
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: NYU Langone Health (`cardio:org-nyu-langone-health`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 4d8623d8d7938c453753e961b49387115850f1a20ca44379cde20f4aa43ebb36
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
